{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:48:20Z","timestamp":1782010100080,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,20]]},"DOI":"10.7759\/cureus.111213","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:27:01Z","timestamp":1782008821000},"source":"Crossref","is-referenced-by-count":0,"title":["Prescription Behaviors of Primary Care Providers in Osteoporosis Management: A Survey"],"prefix":"10.7759","author":[{"given":"Vijayalakshmi","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2020.43156","article-title":"Economic burden of osteoporotic fractures in US managed care enrollees","volume":"26","author":"Williams SA","year":"2020","unstructured":"Williams SA, Chastek B, Sundquist K, et al.. Economic burden of osteoporotic fractures in US managed care enrollees. Am J Manag Care. 2020, 26:e142-9. 10.37765\/ajmc.2020.43156","journal-title":"Am J Manag Care"},{"key":"ref2","article-title":"Osteoporosis: a review of treatment options","volume":"43","author":"Tu KN","year":"2018","unstructured":"Tu KN, Lie JD, Wan C, et al.. Osteoporosis: a review of treatment options. P T. 2018, 43:92-104.","journal-title":"P T"},{"key":"ref3","unstructured":"Learn what osteoporosis is and what it's caused by. (2021). Accessed. March 8, 2022: https:\/\/www.bonehealthandosteoporosis.org\/patients\/what-is-osteoporosis.."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0317","article-title":"Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review","volume":"161","author":"Crandall CJ","year":"2014","unstructured":"Crandall CJ, Newberry SJ, Diamant A, et al.. Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med. 2014, 161:711-23. 10.7326\/M14-0317","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3310\/hta24290","article-title":"Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation","volume":"24","author":"Davis S","year":"2020","unstructured":"Davis S, Simpson E, Hamilton J, et al.. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health Technol Assess. 2020, 24:1-314. 10.3310\/hta24290","journal-title":"Health Technol Assess"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001674","article-title":"Efficacy and safety of denosumab in postmenopausal women with osteoporosis: a meta-analysis","volume":"94","author":"Gu HF","year":"2015","unstructured":"Gu HF, Gu LJ, Wu Y, Zhao XH, Zhang Q, Xu ZR, Yang YM. Efficacy and safety of denosumab in postmenopausal women with osteoporosis: a meta-analysis. Medicine (Baltimore). 2015, 94:e1674. 10.1097\/MD.0000000000001674","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-9-150","article-title":"Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey","volume":"9","author":"Theodorou M","year":"2009","unstructured":"Theodorou M, Tsiantou V, Pavlakis A, Maniadakis N, Fragoulakis V, Pavi E, Kyriopoulos J. Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. BMC Health Serv Res. 2009, 9:150. 10.1186\/1472-6963-9-150","journal-title":"BMC Health Serv Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050001","article-title":"The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States","volume":"5","author":"Gagnon MA","year":"2008","unstructured":"Gagnon MA, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008, 5:e1. 10.1371\/journal.pmed.0050001","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1509\/jmkr.2005.42.3.278","article-title":"Temporal differences in the role of marketing communication in new product categories","volume":"42","author":"Narayanan S","year":"2005","unstructured":"Narayanan S, Manchanda P, Chintagunta PK. Temporal differences in the role of marketing communication in new product categories. J Mark Res. 2005, 42:278-290. 10.1509\/jmkr.2005.42.3.278","journal-title":"J Mark Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040283","article-title":"Physician awareness of drug cost: a systematic review","volume":"4","author":"Allan GM","year":"2007","unstructured":"Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007, 4:e283. 10.1371\/journal.pmed.0040283","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016408","article-title":"Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review","volume":"7","author":"Fickweiler F","year":"2017","unstructured":"Fickweiler F, Fickweiler W, Urbach E. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review. BMJ Open. 2017, 7:e016408. 10.1136\/bmjopen-2017-016408","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2021.01.012","article-title":"What influences healthcare providers' prescribing decisions? Results from a national survey","volume":"17","author":"Price SM","year":"2021","unstructured":"Price SM, O'Donoghue AC, Rizzo L, Sapru S, Aikin KJ. What influences healthcare providers' prescribing decisions? Results from a national survey. Res Social Adm Pharm. 2021, 17:1770-9. 10.1016\/j.sapharm.2021.01.012","journal-title":"Res Social Adm Pharm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2020.02.190278","article-title":"Direct-to-consumer prescription drug advertising and patient-provider interactions","volume":"33","author":"Sullivan HW","year":"2020","unstructured":"Sullivan HW, Aikin KJ, Berktold J, Stein KL, Hoverman VJ. Direct-to-consumer prescription drug advertising and patient-provider interactions. J Am Board Fam Med. 2020, 33:279-83. 10.3122\/jabfm.2020.02.190278","journal-title":"J Am Board Fam Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200119020-00001","article-title":"Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers","volume":"19","author":"Findlay SD","year":"2001","unstructured":"Findlay SD. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers. Pharmacoeconomics. 2001, 19:109-19. 10.2165\/00019053-200119020-00001","journal-title":"Pharmacoeconomics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igx004.1963","article-title":"Are knowledge and locus of control important factors in reducing racial inequities in osteoporosis?","volume":"1","author":"Wright NC","year":"2017","unstructured":"Wright NC, Melton ME, Ivankova NV, Davies SL, Levitan E, Saag KG. Are knowledge and locus of control important factors in reducing racial inequities in osteoporosis?. Innov Aging. 2017, 1:557-8. 10.1093\/geroni\/igx004.1963","journal-title":"Innov Aging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-1077-7","article-title":"Influence of patient race on physician prescribing decisions: a randomized on-line experiment","volume":"24","author":"Rathore SS","year":"2009","unstructured":"Rathore SS, Ketcham JD, Alexander GC, Epstein AJ. Influence of patient race on physician prescribing decisions: a randomized on-line experiment. J Gen Intern Med. 2009, 24:1183-91. 10.1007\/s11606-009-1077-7","journal-title":"J Gen Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115125","article-title":"Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018","volume":"130","author":"Agirrezabal I","year":"2020","unstructured":"Agirrezabal I, Cabas\u00e9s JM, Di Tanna GL, S\u00e1nchez-Iriso E. Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018. Bone. 2020, 130:115125. 10.1016\/j.bone.2019.115125","journal-title":"Bone"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1752-4","article-title":"Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study","volume":"16","author":"Tseng CW","year":"2016","unstructured":"Tseng CW, Lin GA, Davis J, et al.. Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study. BMC Health Serv Res. 2016, 16:499. 10.1186\/s12913-016-1752-4","journal-title":"BMC Health Serv Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0016-z","article-title":"Exploring physician specialist response rates to web-based surveys","volume":"15","author":"Cunningham CT","year":"2015","unstructured":"Cunningham CT, Quan H, Hemmelgarn B, et al.. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol. 2015, 15:32. 10.1186\/s12874-015-0016-z","journal-title":"BMC Med Res Methodol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0253717620957496","article-title":"The limitations of online surveys","volume":"42","author":"Andrade C","year":"2020","unstructured":"Andrade C. The limitations of online surveys. Indian J Psychol Med. 2020, 42:575-6. 10.1177\/0253717620957496","journal-title":"Indian J Psychol Med"},{"key":"ref21","unstructured":"Prolia (denosumab). (2025). Accessed. May 10, 2026: https:\/\/www.prolia.com\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00193","article-title":"Women's values and preferences regarding osteoporosis treatments: a systematic review","volume":"104","author":"Barrionuevo P","year":"2019","unstructured":"Barrionuevo P, Gionfriddo MR, Castaneda-Guarderas A, et al.. Women's values and preferences regarding osteoporosis treatments: a systematic review. J Clin Endocrinol Metab. 2019, 104:1631-6. 10.1210\/jc.2019-00193","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0217-1","article-title":"Racial and socioeconomic disparities in bone density testing before and after hip fracture","volume":"22","author":"Neuner JM","year":"2007","unstructured":"Neuner JM, Zhang X, Sparapani R, Laud PW, Nattinger AB. Racial and socioeconomic disparities in bone density testing before and after hip fracture. J Gen Intern Med. 2007, 22:1239-45. 10.1007\/s11606-007-0217-1","journal-title":"J Gen Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/07359683.2021.1947067","article-title":"Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey","volume":"38","author":"Aikin KJ","year":"2021","unstructured":"Aikin KJ, Sullivan HW, Berktold J, Stein KL, Hoverman VJ. Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey. Health Mark Q. 2021, 38:1-11. 10.1080\/07359683.2021.1947067","journal-title":"Health Mark Q"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/497131-prescription-behaviors-of-primary-care-providers-in-osteoporosis-management-a-survey","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:27:03Z","timestamp":1782008823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/497131-prescription-behaviors-of-primary-care-providers-in-osteoporosis-management-a-survey"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.111213","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}